While you're here, check out some of our work if you're interested! https://t.co/fDGBHqZNZn https://t.co/73WK7fEYQO https://t.co/J2vmMVLyiQ https://t.co/adShMU3Jf2
@kanishkavbs Here are some papers our team has recently published: https://t.co/73WK7fEYQO https://t.co/Jot8ASfkBj https://t.co/adShMU3Jf2
@SonyaBuyting And some other recent work from our team that might be of interest: https://t.co/adShMU3Jf2 https://t.co/73WK7fEYQO
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
RT @doctorsoumya: Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvir…
Clinical trials need to be done to test various potential therapeutics. Some clues from drugs tested on other #coronarvirus but the proof will lie with RCTs. @WHO @rd_blueprint is developing a framework for prioritization. Equitable access to efficacious d
RT @VirusWhisperer: Very nice & independent corroboration of Chinese reports that type I IFN SPRAY prophylaxis might be effective and some…
@CarlosdelRio7 @dskinfdis @PaulSaxMD @CDCDirector @WHO @SouthAfricanASP @doctorsoumya @GermHunterMD @V2019N @jonotter @JeremyFarrar @CDCgov @BradSpellberg @neleshg @TorontoIDDoc I'm not a structural biologist, but "broad-spectrum" antivirals are very rare.
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @VirusWhisperer: Very nice & independent corroboration of Chinese reports that type I IFN SPRAY prophylaxis might be effective and some…
@profchloeorkin @sanjaybhagani @nicolamlow @JeremyFarrar @Laurie_Garrett @richardhorton1 @onisillos There are several mentions of ongoing plans to try antivirals. In this article, remdesivir & IFNb has shown superior antiviral activity against MERS-CoV
Emendation: References [1] https://t.co/jfrQLMxqzK [2] https://t.co/XjjCK8G0nq [3] https://t.co/1RIbS9AD9q [4] https://t.co/gs7F940Hgi [5] https://t.co/f4orc0WdT5
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against #MERSCoV , Sheahan et al., Jan. 2020 @NatureComms #coronavirus #CoronavirusOutbreak
RT @Nichapa079: Remdesivir (RDV) มีแนวโน้มว่าจะเป็นยาที่ดีที่สุดในการรักษา CoV แต่ยังไม่ออกวางขายนะคะ รอตรวจสอบความปลอดภัยและผลข้างเคียงต่า…
RT @Nichapa079: Remdesivir (RDV) มีแนวโน้มว่าจะเป็นยาที่ดีที่สุดในการรักษา CoV แต่ยังไม่ออกวางขายนะคะ รอตรวจสอบความปลอดภัยและผลข้างเคียงต่า…
RT @Nichapa079: Remdesivir (RDV) มีแนวโน้มว่าจะเป็นยาที่ดีที่สุดในการรักษา CoV แต่ยังไม่ออกวางขายนะคะ รอตรวจสอบความปลอดภัยและผลข้างเคียงต่า…
Remdesivir (RDV) มีแนวโน้มว่าจะเป็นยาที่ดีที่สุดในการรักษา CoV แต่ยังไม่ออกวางขายนะคะ รอตรวจสอบความปลอดภัยและผลข้างเคียงต่างๆ ,, ที่ไทยมีแต่ Lopi/rito ค่ะ สนใจอ่านต่อได้ที่ https://t.co/0xSC9nvcO0 #ไวรัสโคโรนาสายพันธุ์ใหม่2019 https://t.co/ZEODOk1qpW
References [1] https://t.co/jfrQLMxqzK [2] https://t.co/XjjCK8G0nq [3] https://t.co/1RIbS9AD9q [3] https://t.co/f4orc0WdT5 [4] https://t.co/f4orc0WdT5
RT @NatureComms: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @Sciguy999: A timely @NatureComms paper from the Baric lab in MICE. Comparative therapeutic efficacy of remdesivir & combination lopinav…
RT @Sciguy999: A timely @NatureComms paper from the Baric lab in MICE. Comparative therapeutic efficacy of remdesivir & combination lopinav…
RT @Sciguy999: A timely @NatureComms paper from the Baric lab in MICE. Comparative therapeutic efficacy of remdesivir & combination lopinav…
@gmleunghku
RT @Sciguy999: A timely @NatureComms paper from the Baric lab in MICE. Comparative therapeutic efficacy of remdesivir & combination lopinav…
こんなデータ見せられたらギリアドの株買いたくなりますね。https://t.co/7N1CTqVtMD (これはnatureではなく姉妹紙です)
@florian_krammer Antivirals including remdesivir https://t.co/r596SFFO2V
RT @Sciguy999: A timely @NatureComms paper from the Baric lab in MICE. Comparative therapeutic efficacy of remdesivir & combination lopinav…
A timely @NatureComms paper from the Baric lab in MICE. Comparative therapeutic efficacy of remdesivir & combination lopinavir, ritonavir, & IFN-beta against MERS-CoV https://t.co/DYipSm3jKY #Wuhan #coronaviruses #wuhanvirus #virus @uncresearch @V
[ Wuhan #Coronavirus Antiviral Treatment ] . เบื้องต้นนักวิจัยยีน เสนอว่า ยาที่ใช้ในการรักษาไวรัส 2019-nCoV น่าจะเป็นยาในกลุ่ม remdesivir จากการวิเคราะห์ RNA polymerase ของไวรัส แต่ยังไม่มีใครสามารถยืนยันรับรองได้ . อ้างอิง: - https://t.co/mBVxNijzeB - h
RT @AntiviralsRule: Remdesivir (=GS-5734) inhibits different zoonotic coronaviruses, also in early therapeutic setting (animal models). It…
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV | Nature Communications https://t.co/ypR46U27wF
RT @NatureComms: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @AntiviralsRule: Remdesivir (=GS-5734) inhibits different zoonotic coronaviruses, also in early therapeutic setting (animal models). It…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
Remdesivir (=GS-5734) inhibits different zoonotic coronaviruses, also in early therapeutic setting (animal models). It was in clinical trials for Ebola so it may improve disease outcomes in #Wuhan #coronavirus -patients. https://t.co/velYrm3Nun https://t.
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @NatureComms: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV…
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV @timothysheahan @Baric_Lab @DenisonLab https://t.co/UpxrF30jBS https://t.co/uAejOlNGXj
RT @OoR_UNC: Dr. Ralph Baric ( #UNC SOM #Microbiology & #Immunology, SPH #Epidemiology) is the senior author of a @NatureComms paper showin…
Dr. Ralph Baric ( #UNC SOM #Microbiology & #Immunology, SPH #Epidemiology) is the senior author of a @NatureComms paper showing that remdesivir could treat infections caused by MERS-CoV - the causative agent of a severe respiratory disease. More here:
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. https://t.co/7aMkqHZctR
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. https://t.co/r9oBvfAueS
RT @ISARICAR: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV | N…
RT @ISARICAR: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV | N…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
Excellent timing! https://t.co/V8QTlnrFXG
RT @Baric_Lab: Check out our latest work led by @timothysheahan on anti-viral treatment of MERS-CoV infection. Great collaborative project…
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV | Nature Communications https://t.co/H7aSKxxb9E
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @NIAIDNews: NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scienti…
NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scientists also exploring remdesivir as a treatment for Ebola, Nipah and other viruses. https://t.co/1R94W5syV1 https://t.co/TfWmLgovFZ
Timely, indeed! Nice work.
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
Wow a very timely study - remdesivir reduces MERS-CoV replication and disease, both for prophylaxis and treatment, in a mouse model by @Timothysheahan at UNC. #SARS #MERS #WuhanPneumonia https://t.co/lGvW1ssEqF
RT @Baric_Lab: Check out our latest work led by @timothysheahan on anti-viral treatment of MERS-CoV infection. Great collaborative project…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @greg_folkers: .@NatureComms: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta a…
.@NatureComms: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against #MERS-CoV #coronavirus https://t.co/ZbD2VeZaBS https://t.co/T8icat3Lhw
Check out our latest work led by @timothysheahan on anti-viral treatment of MERS-CoV infection. Great collaborative project with very timely results!
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
I forgot to add @aschaefe29 to the list here as she made significant contributions!
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
RT @timothysheahan: Our timely new pub on a broad-spectrum antiviral for emerging coronavirus. Took a village @DenisonLab @Baric_Lab @Sarah…
Check out the new publication from our lab! As always a pleasure working with you, @timothysheahan!